This slide details the implications of Pfizer's announcement to restrict the sale of drugs that could be used for lethal injection ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
However, the study found that a third dose of the Pfizer vaccine, and mixing Pfizer and AstraZeneca preventives may protect ...
Bengaluru: The Special Investigation Team (SIT) probing an alleged counterfeit pharmaceutical racket in Karnataka has ...
The SIT investigating the alleged fake pharmaceutical racket helmed by a former medical representative based in Karnataka has said that the probe traced overseas links in Turkiye who supplied original ...
Pfizer (PFE) announces the FDA approval of oral therapy Tukysa as part of a combination regimen for a type of breast cancer in a front-line setting. Read more here.
Acquisition adds specialist injection moulding expertise, an experienced team and a strong platform for further growth ...
Investor's Business Daily on MSN
Vaxcyte catapults after going toe-to-toe with Pfizer, Merck in vaccine study
Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from ...
U.S. states’ methods for obtaining the drugs used in carrying out executions are shrouded in secrecy.
Pfizer's tilrekimig met the Phase II endpoint in atopic dermatitis, improving Week 16 EASI-75 responses across doses versus ...
Pfizer Inc. (NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with ...
Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results